Elkhorn Partners Limited Partnership Buys McDermott International Inc, ProShares Short Dow30, Sells Equitable Financial Corp, Gilead Sciences Inc, OPKO Health Inc

Nov 14, 2018

Elkhorn, NE, based Investment company Elkhorn Partners Limited Partnership buys McDermott International Inc, ProShares Short Dow30, sells Equitable Financial Corp, Gilead Sciences Inc, OPKO Health Inc, VIVUS Inc during the 3-months ended 2018-09-30, according to the most recent filings of the investment company, Elkhorn Partners Limited Partnership. As of 2018-09-30, Elkhorn Partners Limited Partnership owns 30 stocks with a total value of $171 million. These are the details of the buys and sells.

New Purchases: MIQ2, DOG,
Added Positions: DWDP, GS, ERII, OBE, PLM,
Reduced Positions: WTM, AAPL, OPK, CTO, DO, GOOG, JPM, INOD, JEF,
Sold Out: EQFN, GILD, VVUS,

For the details of ELKHORN PARTNERS LIMITED PARTNERSHIP's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=ELKHORN+PARTNERS+LIMITED+PARTNERSHIP

These are the top 5 holdings of ELKHORN PARTNERS LIMITED PARTNERSHIP

Kennedy-Wilson Holdings Inc (KW) - 4,373,200 shares, 55.12% of the total portfolio. Shares reduced by 0.26%
White Mountains Insurance Group Ltd (WTM) - 26,000 shares, 14.26% of the total portfolio. Shares reduced by 6.63%
Berkshire Hathaway Inc (BRK.A) - 50 shares, 9.38% of the total portfolio.
Berkshire Hathaway Inc (BRK.B) - 59,800 shares, 7.51% of the total portfolio.
Cadiz Inc (CDZI) - 837,000 shares, 3.08% of the total portfolio. Shares reduced by 0.02%

New Purchase: McDermott International Inc (MIQ2)

Elkhorn Partners Limited Partnership initiated holding in McDermott International Inc. The purchase prices were between $14.8 and $17.8, with an estimated average price of $16.04. The stock is now traded at around $7.67. The impact to a portfolio due to this purchase was 0.56%. The holding were 52,000 shares as of 2018-09-30.

New Purchase: ProShares Short Dow30 (DOG)

Elkhorn Partners Limited Partnership initiated holding in ProShares Short Dow30. The purchase prices were between $54.4 and $60.11, with an estimated average price of $56.86. The stock is now traded at around $57.17. The impact to a portfolio due to this purchase was 0.37%. The holding were 11,500 shares as of 2018-09-30.

Sold Out: Equitable Financial Corp (EQFN)

Elkhorn Partners Limited Partnership sold out a holding in Equitable Financial Corp. The sale prices were between $10.4 and $12.8, with an estimated average price of $11.41.

Sold Out: Gilead Sciences Inc (GILD)

Elkhorn Partners Limited Partnership sold out a holding in Gilead Sciences Inc. The sale prices were between $71.28 and $78.92, with an estimated average price of $75.46.

Sold Out: VIVUS Inc (VVUS)

Elkhorn Partners Limited Partnership sold out a holding in VIVUS Inc. The sale prices were between $4.41 and $8.22, with an estimated average price of $6.28.

Here is the complete portfolio of ELKHORN PARTNERS LIMITED PARTNERSHIP. Also check out:

1. ELKHORN PARTNERS LIMITED PARTNERSHIP's Undervalued Stocks
2. ELKHORN PARTNERS LIMITED PARTNERSHIP's Top Growth Companies, and
3. ELKHORN PARTNERS LIMITED PARTNERSHIP's High Yield stocks
4. Stocks that ELKHORN PARTNERS LIMITED PARTNERSHIP keeps buying

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Data is updated daily.